Found 8 matching trials
DL-3-n-butylphthalide Treatment in Patients With Mild to Moderate Alzheimer's Disease Already Receiving Donepezil
N/AAlzheimer's disease (AD) is the commonest cause of dementia. There is no ef...
Location
First Affiliated Hospital of Xi'an Jiaotong University
NBP in Patients With Moyamoya Disease of High Risk for Ischemic Cerebrovascular Events
PHASE3An extracranial-to-intracranial (EC-IC) revascularization is the most widel...
Location
Beijing Tiantan Hospital, Capital Medical University
The Efficacy of DL-NBP in Patients With Mild Subcortical Ischemic Vascular Dementia
NAThis is a 48-week, double-blind, randomized, placebo-controlled study. Sixt...
Location
Tianjin Medicial University General Hospital
Effect of Butyphthalide on Cognitive Level Change After Cerebral Vascular Event-a Randomized Control Trial (Be-CLEVER)
PHASE3Post-stroke cognitive impairment (PSCI) refers to a clinical syndrome chara...
Location
Donggang Center Hospitol
Effects of DL-3-n-butylphthalide on Chemotherapy-Induced Cognitive Impairment
PHASE4Chemotherapy-related cognitive Impairment (CICI) is a series of neurocognit...
Location
Multiple Locations
Butylphthalide for Cognitive Impairment in Elderly Patients With Focal Epilepsy
PHASE4This is a multicenter, randomized, double-blind, placebo-controlled trial e...
Location
First Affiliated Hospital of Wenzhou Medical University
The Efficacy of Butylphthalide Soft Capsules in Patents With VCIND
PHASE2Vascular cognitive impairment no dementia (VCIND) is very common among the ...
Location
Second Affiliated Hospital of Hebei medical university
Dl-3-n-butylphthalide and Cerebrolysin Treatment in Acute Ischemic Stroke
PHASE1The investigators conducted a randomized, double-blind, trial enrolled 60 p...
Location
Shanghai Sixth People's Hospital